Source: Annual Congress 2001 - Analyses of airway secretions, biopsies and serum in airway disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. J. Meachery, C. Greene, S. J. O'Neill, N. G. McElvaney (Dublin, Ireland). Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis. Eur Respir J 2001; 16: Suppl. 31, 2523

Member's Comments

No comment yet.

Related content which might interest you: Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001 Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Interleukin-6, interleukin-12 and interleukin-18 gene polymorphisms in Slovenian sarcoidosis patients Source: Annual Congress 2007 - The role of gene polymorphisms in pulmonary disease susceptibility Year: 2007 TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Lung expression of interleukin-13 (IL-13) and interferon gamma (IFNg) in emphysema in human Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002 IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Interleukin-18 and interleukin-18 receptor-? expression in allergic asthma Source: Eur Respir J 2011; 38: 981-983 Year: 2011 Serum levels of IL-10 and IL-12p40 in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007 Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006 Interleukin-10 and interferon-gamma levels in blood serum in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 The production of IL-18, IL-12 and TNF-alpha by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis Source: Eur Respir J 2003; 22: Suppl. 45, 177s Year: 2003 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients Source: Eur Respir J 2007; 30: 701-707 Year: 2007 Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Upregulation of interleukin 13 receptor alpha 2 (IL-13RA2) expression in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 TNF-alpha and TNF-beta gene polymorphism in pulmonary sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006 Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002 Interleukin-12 receptor mRNA expression and corticosteroid depended eosinophil apoptosis in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 223s Year: 2003